Newsroom

LONDON--(BUSINESS WIRE)--  Re: Atlas Holdings 2025-1 Limited GBP 4,752,000.00 MATURING: 20-Jul-2062 ISIN: XS3037719138 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 20-Jan-2026 HAS BEEN FIXED AT 7.79 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 20-Jan-2026 WILL AMOUNT TO: GBP 29,413.40 PER GBP 4,752,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: ATLAS FUNDING 2023 -1 PLC GBP 2,289,000.00 MATURING: 20-Jan-2061 ISIN: XS2601815645 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 20-Jan-2026 HAS BEEN FIXED AT 11.29 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 20-Jan-2026 WILL AMOUNT TO: GBP 7,715.11 PER GBP 860,051.06 DENOMINATION  ...

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired CoreWeave, Inc. (NASDAQ: CRWV) securities between March 28, 2025 and December 15, 2025. CoreWeave purports to be an artificial intelligence (“AI”) cloud computing company and self-described “Hyperscaler”, which it defines as “a cloud provider or technology company that is capable of delivering computing infrastructure and services at massive s...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Polaris Capital Management, LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must b...

LONDON--(BUSINESS WIRE)--  Re: ATLAS FUNDING 2023 -1 PLC GBP 248,266,000.00 MATURING: 20-Jan-2061 ISIN: XS2601487619 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 22-Dec-2025 TO 20-Jan-2026 HAS BEEN FIXED AT 4.94 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 20-Jan-2026 WILL AMOUNT TO: GBP 839,778.04 PER GBP 213,938,271.04 DENOMINATION  ...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), società oncologica globale, evidenzierà i pilastri della sua crescente leadership oncologica globale durante la sua presentazione oggi alla 44a Annual Healthcare Conference di J.P. Morgan a San Francisco. John V. Oyler, Cofondatore, Presidente e CEO di BeOne, evidenzierà la leadership innovativa della Società nella terapia dei tumori maligni a cellule B. La presentazione includerà BRUKINSA®, l'ini...

SAN CARLOS, Kalifornien--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), ein weltweit tätiges Onkologieunternehmen, wird im Rahmen seiner heutigen Präsentation auf der 44. jährlichen J.P. Morgan Healthcare Conference in San Francisco die Grundpfeiler seiner zunehmenden globalen Führungsrolle auf dem Gebiet der Onkologie vorstellen. John V. Oyler, Mitbegründer, Chairman und CEO von BeOne, wird die transformative Vorreiterrolle des Unternehmens bei der Behandlung vo...

LONDON--(BUSINESS WIRE)--  Re: Bausch+Lomb Netherlands B.V. EUR 651,827,000.00 MATURING: 15-Jan-2031 ISIN: XS3102032201 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 15-Jan-2026 TO 15-Apr-2026 HAS BEEN FIXED AT 5.89 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 15-Apr-2026 WILL AMOUNT TO: EUR 9,737,086.63 PER EUR 661,150,000.00 DENOMINATION  ...

SAN CARLOS, Californie--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ : ONC ; HKEX : 06160 ; SSE : 688235), une société mondiale spécialisée en oncologie, présentera les piliers de son leadership mondial croissant en oncologie lors de sa présentation aujourd’hui à la 44e J.P. Morgan Healthcare Conference annuelle à San Francisco. John V. Oyler, cofondateur, président-directeur général de BeOne, mettra en avant le leadership transformateur de la société dans le traitement des malignités à cellul...

SAN FRANCISCO--(BUSINESS WIRE)--Textio, a leader in building tools that help high-growth companies recruit and coach high-performing teams, today announced that its board has appointed Colleen Gallagher, currently Chief Operating Officer, as the company’s next Chief Executive Officer. Jensen Harris, Textio’s founding CTO and CEO for the last two years, will return to the CTO role and continue to guide the company’s technical direction, in addition to remaining on the board. Gallagher assumes th...